AWS GraphRAG deployment cuts drug research cycles by 87%
A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This…
Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic…
NVIDIA BioNeMo accelerates Anthropic Claude Science
Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has…
Deploying retail AI to scale personalisation and customer insight
Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing…
Anthropic deploys Claude Sonnet 5, Fable and Mythos restored
Anthropic has launched Claude Sonnet 5 and restored access to its Fable and Mythos frontier models following a…
HP accelerates enterprise workflows with OpenAI Frontier
HP has scaled its OpenAI Frontier integration across global operations to optimise enterprise workflows and accelerate output. The…
xFusion scales enterprise AI from edge workstations to liquid-cooled data centres
xFusion presented scalable enterprise AI computing models at ISC 2026, transitioning hardware from edge devices to data centres.…
SAP aligns commerce data for AI personalisation
SAP aligns fragmented commerce data structures to enable operational AI personalisation at the execution layer. Enterprise leadership routinely…
Omio scales travel product development using OpenAI models
Omio integrates OpenAI models across its engineering operations to accelerate travel product development and launch booking interfaces. The…
Mitigating vendor lock-in with Sakana AI Fugu multi-agent models
Sakana AI launched Fugu to orchestrate multi-agent operations and mitigate single-vendor dependency risks in enterprise deployments. Enterprises face…